CIK 0001582554
- Non-accelerated filer
- Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463011414
- Phone
- +1 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Grant or award Director acquired 31,579 shares (grant or award)
- 4 Grant or award Director acquired 11,760 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 750,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Scientific Officer bought 5,000 shares at $1.41 ($7,050)
- 4 Open-market buy Director bought 100,000 shares at $1.38 ($138,000)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.36 ($6,800)
- 4 Open-market buy Director bought 5,000 shares at $1.24 ($6,200)
- 4 Open-market buy Director bought 100,000 shares at $1.30 ($130,000)
- 4 Open-market buy Director bought 5,000 shares at $1.29 ($6,450)
- 4/A Derivatives Options or other derivatives
- 4 Other disposition Shareholder disposed of 10,496,760 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 11 of 12 · 232 filings